First National Advisers, LLC Horizon Therapeutics Public LTD CO Transaction History

First National Advisers, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	BUY	$98.98 - $115.74 $404,531 - $473,029	4,087 Added 66.16%	10,264 $1.19 Million
Q2 2023 Aug 11, 2023	BUY	$96.34 - $112.38 $7,610 - $8,878	79 Added 1.3%	6,177 $635,000
Q1 2023 May 10, 2023	SELL	$107.32 - $113.5 $726,771 - $768,622	-6,772 Reduced 52.62%	6,098 $665,000
Q4 2022 Feb 09, 2023	BUY	$62.39 - $113.8 $82,167 - $149,874	1,317 Added 11.4%	12,870 $1.46 Million
Q3 2022 Nov 04, 2022	BUY	$58.92 - $84.67 $263,490 - $378,644	4,472 Added 63.15%	11,553 $715,000

Q2 2022 Aug 12, 2022	BUY	$79.4 - $116.36 $562,231 - $823,945	7,081 New	7,081 $565,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of First National Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on First National Advisers, LLC with notifications on news.